comparemela.com
  1. Home
  2. Live Updates
  3. Trillium Therapeutics - Breaking News

Latest Breaking News On - Trillium therapeutics - Page 7 : comparemela.com

Oncolytics Biotech : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 9, 2023 - Form 6-K

NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 9, 2023 - AND - MANAGEMENT INFORMATION CIRCULAR . | April 6, 2023

United statesUnited kingdomNew yorkNew jerseyPrinceton universityUniversity of daytonLeonard kruimerMatt coffeyBristol myers squibbThomasc heinemanJonathan rigbyAllison hagermanDeborah brownMichael bennettWayne pisanoDeborahm brown

Pfizer bought cancer biotech Seagen for $43 billion cash

Pfizer CEO paid $43 billion in cash for Seagen, which makes an innovative cancer treatment

Bristol myers squibbArena pharmaceuticalTrillium therapeuticsLife sciencesBristol myers squibbPharmaceutical industryArena pharmaceutical

Form 8-K Viridian Therapeutics, For: Feb 06

Form 8-K Viridian Therapeutics, For: Feb 06
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesKristian humerScott myersSalary target bonusRainier therapeutics incCircassia pharmaceuticalsPfizer incCascadian therapeutics incPharmaceuticals incViridian therapeutics incUniversity of chicago booth school businessTrillium therapeutics incDynavax technologies corporationBioclin therapeutics incSelecta biosciences incSecurities exchange

Viridian Therapeutics, Inc: Viridian Appoints Scott Myers as President and Chief Executive Officer

WALTHAM, Mass., Feb. 06, 2023 (GLOBE NEWSWIRE) Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious

United statesTodd jamesCovis pharmaSelecta biosciencesSchwierige zeitenNeither the companyUniversity of chicago booth school businessCompany under scottMaster of business administrationExchange commissionCompany annual report on formViridian therapeutics incNorthwestern universityCorporate affairsScott myersChief executive officer

TIGIT Inhibitors Clinical Trial Pipeline Appears Robust with 18+ Key Pharma Players Actively Working in the Space, Estimates DelveInsight

/PRNewswire/ DelveInsight s TIGIT Inhibitors Competitive Landscape – 2022 report provides comprehensive global coverage of available, marketed, and.

United statesUnited kingdomShruti thakurAscentage pharmaBeigene ociperlimabLinton pharmEli lillyMereo biopharmaBristol myers squibbUniversity collaborations licensing partnering analysisZhongqi pharmaceutical technology co ltdMerck coPhio pharmaceuticalsBio thera solutionsNovartis pharmaceuticalsHealthcare services

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.